AIM ImmunoTech (AIM) EBT Margin (2010 - 2026)
AIM ImmunoTech (AIM) recorded EBT Margin of -14646.15% in Q2 2026, down 3466.15 percentage points from -11180.00% a year earlier and down 3146.15 percentage points from the prior quarter.
AIM ImmunoTech (AIM) EBT Margin (2010 - 2026) Analysis & Trends
On a TTM basis, AIM ImmunoTech's EBT Margin came in at -12922.11% as of Jun 30, 2026, up 1305.99 percentage points year-over-year; for FY2025, it was -14177.27%, down 2202.57 percentage points from FY2024.
- Annual EBT Margin has a five-year change of -4431.87 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at -11974.71% in FY2024 (+3825.29 pp), -15800.00% in FY2023 (-1670.21 pp), -14129.79% in FY2022 (-112.01 pp) and -14017.78% in FY2021 (-4272.38 pp).
- Quarterly EBT Margin has ranged from -31052.38% in Q3 2022 to -7746.00% in Q2 2024 over the past five years.
- On a year-over-year basis, EBT Margin rose in four of the last eight quarters, with an average year-over-year change of +1186.53 percentage points.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 13319.77 percentage points in Q3 2023, against a drop of 19085.71 percentage points in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -11500.00% (Q1 2026), -15919.05% (Q4 2025) and -9980.77% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | AIM ImmunoTech | 3.08 Mn | -18.22 Mn | 21,000.00 | -14,646.15% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14,646.15% |
| Mar 31, 2026 | -11,500.00% |
| Dec 31, 2025 | -15,919.05% |
| Sep 30, 2025 | -9,980.77% |
| Jun 30, 2025 | -11,180.00% |
| Mar 31, 2025 | -23,393.75% |
| Dec 31, 2024 | -13,304.44% |
| Sep 30, 2024 | -13,402.86% |
| Jun 30, 2024 | -7,746.00% |
| Mar 31, 2024 | -14,515.00% |
| Dec 31, 2023 | -21,544.62% |
| Sep 30, 2023 | -17,732.61% |
| Jun 30, 2023 | -13,002.38% |
| Mar 31, 2023 | -8,765.31% |
| Dec 31, 2022 | -9,921.43% |
| Sep 30, 2022 | -31,052.38% |
| Jun 30, 2022 | -15,386.67% |
| Mar 31, 2022 | -9,415.15% |
| Dec 31, 2021 | -14,794.00% |
| Sep 30, 2021 | -11,966.67% |
AIM ImmunoTech EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=AIM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();